PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Medicine10.3904/kjm.2013.84.5.7422013845742Successful Rechallenge with Darbepoetin Following Immunosuppressive Therapy in a Dialysis Patient with Erythropoietin-Induced Pure Red Cell AplasiaIn-Sung Son, Do-Young Kim, Soo-Youn Park, Ha-Young Na, Jung-Hyun Lee, Tae-Hwe Heo, Young-Il Johttp://synapse.koreamed.org/pdf/10.3904/kjm.2013.84.5.742, http://synapse.koreamed.org/DOIx.php?id=10.3904/kjm.2013.84.5.742
Clinical & Laboratory Haematology10.1111/j.1365-2257.1993.tb00125.x200815168-70Spontaneous remission of chronic pure red cell aplasia after failure of immunosuppressive therapyJ. Wright, M. Greaveshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2257.1993.tb00125.x
Pediatric Nephrology10.1007/s00467-013-2580-y2013291161-162Recovery of native erythropoietin in a patient with erythropoietin-associated pure red cell aplasiaKristina M. Prus, Mohamad M. Al-Rahawanhttp://link.springer.com/content/pdf/10.1007/s00467-013-2580-y.pdf, http://link.springer.com/article/10.1007/s00467-013-2580-y/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00467-013-2580-y
Reactions Weekly10.1007/s40278-015-2831-820151557181-81Darbepoetin-α/epoetin-αhttp://link.springer.com/content/pdf/10.1007/s40278-015-2831-8.pdf, http://link.springer.com/article/10.1007/s40278-015-2831-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-2831-8
Reactions Weekly10.1007/s40278-015-9646-5201515471107-107Darbepoetin-α/epoetin-α/epoetin-βhttp://link.springer.com/content/pdf/10.1007/s40278-015-9646-5.pdf, http://link.springer.com/article/10.1007/s40278-015-9646-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-9646-5
Reactions Weekly10.1007/s40278-013-6892-220131476115-15Darbepoetin-α/epoetin-β/epoetin-θhttp://link.springer.com/content/pdf/10.1007/s40278-013-6892-2.pdf, http://link.springer.com/article/10.1007/s40278-013-6892-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-013-6892-2
European Journal of Clinical Investigation10.1111/j.1365-2362.2005.01536.x200535s395-99Erythropoietin-induced, antibody-mediated pure red cell aplasia* https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2362.2005.01536.x
Korean Journal of Medicine10.3904/kjm.2013.85.2.2142013852214Successful Erythropoietin Therapy after Alemtuzumab and Cyclosporin a Treatment for Epoetin-Induced Pure Red Cell AplasiaHyemin Park, Jaeuk Im, Juhwan Park, Enhye Kim, Honggil Jun, Jae-Hoo Park, Hawk Kimhttp://synapse.koreamed.org/pdf/10.3904/kjm.2013.85.2.214, http://synapse.koreamed.org/DOIx.php?id=10.3904/kjm.2013.85.2.214
The Lancet10.1016/s0140-6736(71)90048-11971298771451IMMUNOSUPPRESSIVE TREATMENT OF PURE RED-CELL APLASIAJ. Vilan, K. Rhyner, A. Ganzonihttps://api.elsevier.com/content/article/PII:S0140673671900481?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0140673671900481?httpAccept=text/plain
European Journal of Haematology10.1111/j.1600-0609.1988.tb01183.x2009413212-217Cytotoxic immunosuppressive drug treatment strategy in pure red cell aplasiaFrank C. Firkin, Darryl Maherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0609.1988.tb01183.x